Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
At age 50, you can make catch-up contributions to enhance your retirement savings. Understand how to take full advantage of this opportunity.
4,560 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Juggling a full-time job and a bustling household, one parent stacked eight real estate deals in just two years. This...
A lingering story can ride beside your finances like a 'ghost passenger seat: reality.' This article explores how nar...
Microsoft shares fell Tuesday as investors reassessed the cost of OpenAI bets and growing capital needs, even after a...
Eli Lilly has faced a pullback that can create long-term buying opportunities. This guide explores using a budget-fri...
Market fear is loud, but smart investors look for resilient opportunities. Here’s why I’m adding a tech stock to my p...
A veteran figure in AI, nicknamed the 'godfather ai,' argues big tech prioritizes short-term profits over the endgame...
BTS returns with a high-profile comeback tour after completing military service, signaling a push to reclaim global p...
With $100, you can start building a resilient energy stock portfolio. This guide breaks down the smartest energy stoc...
Is Micron stock a smart move when it trades under $500? This guide breaks down the AI memory market, Micron's role, a...
New SSA data shows benefits rise with age, peaking after delaying retirement credits. But even at 70, many retireesSt...
Could investing $10,000 walmart really boost your wealth? This guide dives into Walmart's growth story, realistic ret...